These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2393975)

  • 1. [Vaccines, cells and nucleic acids].
    Zuckerman AJ; Deinhardt F
    Bull World Health Organ; 1990; 68(3):293-5. PubMed ID: 2393975
    [No Abstract]   [Full Text] [Related]  

  • 2. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
    World Health Organ Tech Rep Ser; 1987; 747():1-29. PubMed ID: 3107222
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA, dragons and sanity.
    Petricciani JC; Horaud FN
    Biologicals; 1995 Sep; 23(3):233-8. PubMed ID: 8527124
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of biological products prepared from mammalian cell culture. Host-cell proteins.
    Dev Biol Stand; 1998; 93():139-40. PubMed ID: 9737394
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hazards in the application of biological products].
    Fernández de Castro J
    Salud Publica Mex; 1978; 20(5):539-57. PubMed ID: 483047
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of biological products prepared from mammalian cell culture. In-process testing for viral agents.
    Dev Biol Stand; 1998; 93():130-1. PubMed ID: 9737389
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammalian cell culture systems for recombinant protein production.
    Birch JR; Froud SJ
    Biologicals; 1994 Jun; 22(2):127-33. PubMed ID: 7917229
    [No Abstract]   [Full Text] [Related]  

  • 8. [Laboratory for the control of serum vaccines and other biological products].
    M'Henni A
    Arch Inst Pasteur Tunis; 1997; 74(1-2):129-33. PubMed ID: 15945193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Requirements for microorganism strains for the preparation of biologicals].
    Selivanov AV; Kirillov LV; Borisovich IuF
    Veterinariia; 1980 Apr; (4):33-5. PubMed ID: 7395074
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of biological products prepared from mammalian cell culture. DNA.
    Dev Biol Stand; 1998; 93():136-8. PubMed ID: 9737393
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologicals production by recombinant DNA technology in Cuba.
    Herrera L; Del la Fuente J; Quinones Y; Padron G; Agraz A; Vega J; Perez L; Silva A; Santizo C; Alvarez R
    Dev Biol Stand; 1989; 70():257-69. PubMed ID: 2503409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the transplantable embryonic cow kidney cell line for preparing anti-foot-and-mouth disease vaccine].
    Kalmykov VA; Nuriev GG; Romanovich TN; Khaertynov SKh
    Veterinariia; 1973 May; 49(5):62-4. PubMed ID: 4726812
    [No Abstract]   [Full Text] [Related]  

  • 14. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 15. Current experience with biological products produced in various continuous cell lines. Summary and conclusions.
    Papermaster BW
    Dev Biol Stand; 1989; 70():227-9. PubMed ID: 2759350
    [No Abstract]   [Full Text] [Related]  

  • 16. The molecular biology of production cell lines.
    Simonsen CC; McGrogan M
    Biologicals; 1994 Jun; 22(2):85-94. PubMed ID: 7917237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum safety requirements for preclinical testing.
    Dorner F; Barrett PN; Schwartz HP; Eibl H
    Dev Biol Stand; 1993; 81():245-52. PubMed ID: 8174809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biosimilar: can we manage biopharmaceutical heterogeneity?].
    Ranieri E
    G Ital Nefrol; 2008; 25(3):275. PubMed ID: 18473296
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of tumor cell stimulation of DNA inhibitory cytokine production in vitro.
    Kieler J; Houssini ME
    Anticancer Res; 1981; 1(4):235-41. PubMed ID: 7049051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologicals: an attempt at classification and its implication for the viral safety of products.
    Horaud F
    Dev Biol Stand; 1993; 81():17-24. PubMed ID: 8174800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.